Loading data
TACTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 51.48 m USD | 43.38 m USD | 72.63 m USD | 58.14 m USD | 39.39 m USD |
| Cost of revenue | 26.47 m USD | 21.9 m USD | 34.23 m USD | 33.73 m USD | 24 m USD |
| Gross profit | 25.02 m USD | 21.48 m USD | 38.4 m USD | 24.41 m USD | 15.38 m USD |
| Research and development expense | 6.7 m USD | 6.98 m USD | 9.44 m USD | 8.57 m USD | 7.48 m USD |
| Operating profit | -1.42 m USD | -3.63 m USD | 5.71 m USD | -7.68 m USD | -9.38 m USD |
| Interest expense | — | — | 310 k USD | 208 k USD | 157 k USD |
| Profit before tax | -1.08 m USD | -3.57 m USD | 5.9 m USD | -7.9 m USD | -6.08 m USD |
| Income tax expense | 156 k USD | 6.3 m USD | 1.16 m USD | -1.97 m USD | -2.04 m USD |
| Net income (reported basis) | -1.24 m USD | -9.86 m USD | 4.75 m USD | -5.94 m USD | -4.04 m USD |
| Basic earnings per share | -0.12 USD/share | -0.99 USD/share | 0.48 USD/share | -0.6 USD/share | -0.43 USD/share |
| Diluted earnings per share | -0.12 USD/share | -0.99 USD/share | 0.47 USD/share | -0.6 USD/share | -0.43 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.